| Literature DB >> 35793952 |
Konosuke Otomaru1, Takuro Miyahara1, Hiroto Saita1, Shinya Yamauchi2, Tomonori Nochi2.
Abstract
The purpose of this study was to determine the effects of vitamin E supplementation on blood oxidative stress biomarker in weaned calves. Thirty clinically healthy 12 weeks of age Japanese Black calves were randomly assigned to two groups: 15 calves received 300 IU of vitamin E daily from 12 to 18 weeks of age (VE group), and the other 15 calves did not receive the vitamin E (control group). Blood samples were taken at 12, 14, 16, 18, and 20 weeks of age. The concentration of serum reactive oxygen metabolites at 20 weeks of age were significantly lower in the VE group than those in the control group. Vitamin E supplementation to weaned calves might affect blood oxidative stress.Entities:
Keywords: Japanese Black calf; oxidative stress; vitamin E; weaned calf
Mesh:
Substances:
Year: 2022 PMID: 35793952 PMCID: PMC9412055 DOI: 10.1292/jvms.22-0170
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.105
The amount and nutrient composition of feed without supplement (per head per day)
| Weeks of age | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 4 | 8 | 12 | 14 | 16 | 18 | 20 | ||
| Amount (dry matter; kg) | |||||||||
| Milk replacer | 0.45 | 0.92 | 0.92 | ||||||
| Calf stater | 0.10 | 0.50 | 1.36 | 1.02 | 0.68 | ||||
| Concentrate | 0.61 | 1.22 | 2.26 | 2.61 | |||||
| Hey (oats) | 0.01 | 0.05 | 0.25 | 0.25 | 0.25 | 0.25 | 0.50 | ||
| Hey (timothy) | 0.26 | 0.43 | 0.95 | 0.95 | |||||
| Composition (dry basis) | |||||||||
| Total Digestible Nutrients | (%) | 101.6 | 99.2 | 93.1 | 77.8 | 74.5 | 73.0 | 70.3 | 70.3 |
| Crude Protein | (%) | 28.2 | 27.3 | 25.0 | 18.5 | 16.8 | 16.1 | 14.7 | 14.3 |
| Crude Fat | (%) | 16.4 | 14.9 | 11.2 | 2.5 | 2.1 | 2.0 | 1.7 | 1.7 |
| Calcium | g/kg | 13.9 | 13.1 | 11.1 | 5.9 | 5.9 | 5.9 | 5.9 | 5.6 |
| Phosphorous | g/kg | 7.3 | 7.1 | 6.6 | 5.1 | 4.7 | 4.5 | 4.1 | 4.1 |
| Magnesium | g/kg | 1.0 | 1.1 | 1.4 | 2.1 | 2.5 | 2.6 | 2.9 | 2.8 |
| Zinc | g/kg | 0.10 | 0.10 | 0.09 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Vitamin E | IU/kg | 27.1 | 25.9 | 23.1 | 15.8 | 15.7 | 15.8 | 15.6 | 15.2 |
Biochemical and vitamin parameters
| Parameter | Weeks of age | |||||
|---|---|---|---|---|---|---|
| 12 | 14 | 16 | 18 | 20 | ||
| ATa) (IU/L) | Vitamin E group | 105 ± 50 | 79 ± 23 | 95 ± 76 | 68 ± 18 | 80 ± 38 |
| Control group | 108 ± 60 | 88 ± 28 | 72 ± 22 | 71 ± 14 | 74 ± 24 | |
| GGTb) (IU/L) | Vitamin E group | 31 ± 11 | 27 ± 9 | 22 ± 7 | 19 ± 4 | 19 ± 4 |
| Control group | 34 ± 15 | 29 ± 11 | 23 ± 5 | 20 ± 4 | 20 ± 5 | |
| CKc) (IU/L) | Vitamin E group | 200 ± 160 | 180 ± 51 | 212 ± 104 | 190 ± 65 | 195 ± 71 |
| Control group | 160 ± 47 | 207 ± 133 | 160 ± 41 | 216 ± 88 | 165 ± 43 | |
| Urea nitrogen (mg/dL) | Vitamin E group | 10.7 ± 2.7 | 10.1 ± 2.0 | 10.5 ± 3.2 | 11.9 ± 3.8 | 11.0 ± 3.9 |
| Control group | 10.8 ± 2.4 | 10.3 ± 2.4 | 10.8 ± 3.1 | 11.9 ± 2.7 | 10.6 ± 3.8 | |
| Creatinine (IU/L) | Vitamin E group | 1.00 ± 0.2 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 |
| Control group | 1.00 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 | 1.0 ± 0.1 | 0.9 ± 0.1 | |
| Total protein (g/dL) | Vitamin E group | 6.2 ± 0.3 | 6.2 ± 0.2 | 6.2 ± 0.3 | 6.2 ± 0.4 | 6.4 ± 0.3 |
| Control group | 6.3 ± 0.5 | 6.2 ± 0.4 | 6.1 ± 0.4 | 6.2 ± 0.6 | 6.2 ± 0.5 | |
| Albumin (g/dL) | Vitamin E group | 3.3 ± 0.1 | 3.3 ± 0.1 | 3.2 ± 0.1 | 3.2 ± 0.2 | 3.2 ± 0.2 |
| Control group | 3.3 ± 0.2 | 3.2 ± 0.2 | 3.2 ± 0.3 | 3.2 ± 0.3 | 3.2 ± 0.2 | |
| Globulin (g/dL) | Vitamin E group | 2.9 ± 0.2 | 2.9 ± 0.1 | 2.9 ± 0.3 | 3.0 ± 0.4 | 3.2 ± 0.3 |
| Control group | 3.0 ± 0.4 | 3.0 ± 0.3 | 2.9 ± 0.3 | 3.0 ± 0.4 | 3.1 ± 0.4 | |
| Albumin/globulin ratio | Vitamin E group | 1.15 ± 0.09 | 1.13 ± 0.06 | 1.12 ± 0.17 | 1.06 ± 0.17 | 1.03 ± 0.16 |
| Control group | 1.10 ± 0.12 | 1.07 ± 0.11 | 1.12 ± 0.13 | 1.06 ± 0.13 | 1.05 ± 0.15 | |
| Total cholesterol (mg/dL) | Vitamin E group | 83 ± 28 | 67 ± 19 | 65 ± 14 | 58 ± 15 | 64 ± 20 |
| Control group | 76 ± 22 | 55 ± 15 | 56 ± 7 | 48 ± 24 | 53 ± 23 | |
| Triglyceride (mg/dL) | Vitamin E group | 11.1 ± 6.0 | 11.7 ± 5.4 | 11.7 ± 5.3 | 8.8 ± 3.3 | 13.6 ± 5.3 |
| Control group | 13.3 ± 4.6 | 12.4 ± 5.7 | 9.9 ± 4.9 | 10.9 ± 6.0 | 11.9 ± 6.5 | |
| BHBd) (μmol/L) | Vitamin E group | 289 ± 76 | 356 ± 76 | 489 ± 187 | 450 ± 97 | 398 ± 74 |
| Control group | 343 ± 115 | 423 ± 127 | 420 ± 96 | 479 ± 157 | 463 ± 119 | |
| Calcium (mg/dL) | Vitamin E group | 10.6 ± 0.4 | 10.7 ± 0.3 | 10.5 ± 0.4 | 10.3 ± 0.5 | 10.4 ± 0.4 |
| Control group | 10.5 ± 0.5 | 10.5 ± 0.4 | 11.1 ± 2.4 | 10.3 ± 0.7 | 10.5 ± 0.5 | |
| Inorganic phosphorus (mg/dL) | Vitamin E group | 8.1 ± 0.7 | 8.5 ± 0.8 | 8.8 ± 0.7 | 8.7 ± 0.8 | 9.1 ± 1.1 |
| Control group | 8.2 ± 1.1 | 8.0 ± 1.5 | 8.3 ± 1.1 | 8.5 ± 1.5 | 8.6 ± 0.9 | |
| Magnesium (mg/dL) | Vitamin E group | 2.7 ± 0.2 | 2.8 ± 0.3 | 2.8 ± 0.2 | 2.7 ± 0.2 | 2.8 ± 0.2 |
| Control group | 2.6 ± 0.2 | 2.7 ± 0.2 | 2.7 ± 0.2 | 2.7 ± 0.2 | 2.7 ± 0.2 | |
| Zinc (μg/dL) | Vitamin E group | 100 ± 16 | 95 ± 17 | 92 ± 16 | 100 ± 19 | 96 ± 19 |
| Control group | 90 ± 23 | 94 ± 15 | 93 ± 15 | 102 ± 23 | 108 ± 20 | |
| Vitamin E (IU/dL) | Vitamin E group | 170 ± 55 | 160 ± 62* | 152 ± 50* | 128 ± 45* | 129 ± 48* |
| Control group | 163 ± 49 | 88 ± 26 | 71 ± 20 | 52 ± 23 | 55 ± 25 | |
a) Aspartate aminotransferase, b) Gamma-glutamyltransferase, c) Creatine kinase, d) Beta-hydroxybutyric acid. Data are shown as mean ± SD. The asterisk indicates a significant difference between groups at the same age (P<0.05).
Fig. 1.(A) Changes in serum reactive oxygen metabolites (d-ROMs) in the vitamin E group (solid squares) and the control group (empty squares). The asterisk indicates a significant difference between groups at the same age (P<0.05). Data are shown as mean ± SD. (B) Changes in serum biological antioxidant potential (BAP) in the vitamin E group (solid squares) and the control group (empty squares). Data are shown as mean ± SD. (C) Changes in oxidative stress index (OSI) in the vitamin E group (solid squares) and the control group (empty squares). The asterisk indicates a significant difference between groups at the same age (P<0.05). Data are shown as mean ± SD. (D) Changes in the serum IgA concentration in the vitamin E group (solid squares) and the control group (empty squares). Data are shown as mean ± SD. (E) Changes in the fecal IgA concentration in the vitamin E group (solid squares) and the control group (empty squares). Data are shown as mean ± SD.
Antibody titers to bovine respiratory syncytial virus
| Animal number | Weeks of age | |||||
|---|---|---|---|---|---|---|
| 12 | 14 | 16 | 18 | 20 | ||
| Vitamin E group | 1 | 8 | 2 | 4 | 8 | 16 |
| 2 | 256 | 512 | 128 | 64 | 32 | |
| 3 | <2 | <2 | 4 | 16 | 4 | |
| 4 | 256 | 256 | 128 | 128 | 32 | |
| 5 | 1,024 | 512 | 1,024 | 256 | 512 | |
| 6 | 256 | 128 | 64 | 32 | 16 | |
| 7 | 2 | <2 | 2 | 2 | 2 | |
| 8 | 2 | <2 | 2 | 2 | 4 | |
| 9 | 32 | 32 | 16 | 16 | 8 | |
| 10 | 64 | 64 | 16 | 8 | 8 | |
| 11 | 4 | 4 | 2 | 2 | 2 | |
| 12 | 1,024 | 256 | 128 | 128 | 32 | |
| 13 | 32 | 16 | 16 | 8 | 4 | |
| 14 | 64 | 32 | 32 | 8 | 8 | |
| 15 | 128 | 64 | 32 | 16 | 16 | |
| 40.3a) | 25.4 | 21.1 | 16.0 | 11.6 | ||
| Animal number | Weeks of age | |||||
| 12 | 14 | 16 | 18 | 20 | ||
| Control group | 1 | 1,024 | 256 | 128 | 128 | 16 |
| 2 | 64 | 16 | 16 | 8 | 16 | |
| 3 | 32 | 32 | 32 | 16 | 32 | |
| 4 | 32 | 64 | 128 | 64 | 64 | |
| 5 | 256 | 128 | 64 | 32 | 8 | |
| 6 | 512 | 256 | 64 | 32 | 32 | |
| 7 | <2 | <2 | 2 | 16 | 8 | |
| 8 | 32 | 8 | 8 | 8 | 4 | |
| 9 | 64 | 64 | 32 | 16 | 4 | |
| 10 | 32 | 8 | 8 | 4 | 4 | |
| 11 | 128 | 32 | 16 | 16 | 8 | |
| 12 | 32 | 8 | 64 | 64 | 64 | |
| 13 | 32 | 32 | 32 | 32 | 32 | |
| 14 | 128 | 128 | 32 | 64 | 32 | |
| 15 | 32 | 16 | 32 | 32 | 16 | |
| 58.4 | 30.6 | 27.9 | 24.3 | 15.3 | ||
a) Geometric mean.